Biotechnology
Healthcare
Investing News
Market News
Technology
The Market Buzz
Brooklyn ImmunoTherapeutics Receives License to Develop Cells to Treat Multiple Cancers & Disorders
Brooklyn ImmoTherapeutics LLC (NYSE: BTX) reported that is has acquired an exclusive license for mRNA gene editing and cell therapies technology of Factor Bioscience Limited and Novellus Therapeutics Limited. ...